Assessment of hyperphagia in Prader-Willi syndrome

被引:137
作者
Dykens, Elisabeth M. [1 ]
Maxwell, Melissa A. [1 ]
Pantino, Elizabeth [1 ]
Kossler, Rebecca [1 ]
Roof, Elizabeth [1 ]
机构
[1] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37203 USA
关键词
psychosocial variables; questionnaire design; genetic susceptibility;
D O I
10.1038/oby.2007.216
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Prader-Willi syndrome (PWS), the leading known genetic cause of obesity, is characterized by intellectual disabilities, maladaptive and compulsive behaviors, and hyperphagia. Although complications of obesity resulting from hyperphagia are the leading cause of death in PWS, quantifying this drive for food has long been an unmet research need. This study provides factor-analytic and within-syndrome analyses of a new measure of hyperphagia in PWS. Research Methods and Procedure: A 13-item informant measure, the Hyperphagia Questionnaire, was developed and administered to the parents of 153 persons with PWS, 4 to 51 years of age. The intelligence quotients, genetic subtypes of PWS, and BMIs of offspring were obtained, as were measures of their non-food problem behaviors. Results: Factor analyses with varimax rotation produced three statistically and conceptually robust factors that accounted for 59% of the variance: Hyperphagic Behaviors, Drive, and Severity. Hyperphagic Behavior increased with age, whereas Drive remained stable, and Severity dipped in older adults. Hyperphagic Drive and Severity were positively correlated with non-food behavior problems, and Hyperphagic Drive differentiated the 36% of participants with extreme obesity from those who had overweight/obese (48%) or healthy (16%) BMI classifications. Discussion: The Hyperphagia Questionnaire is a robust tool for relating breakthroughs in the neurobiology of hyperphagia to in vivo food-seeking behavior and for examining the psychological and developmental correlates of hyperphagia in PWS. The Hyperphagia Questionnaire also offers a nuanced, real-life outcome measure for future clinical trials aimed at curbing the life-threatening drive for food in PWS.
引用
收藏
页码:1816 / 1826
页数:11
相关论文
共 47 条
[21]  
2
[22]   Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance [J].
Eiholzer, U ;
Gisin, R ;
Weinmann, C ;
Kriemler, S ;
Steinert, H ;
Torresani, T ;
Zachmann, M ;
Prader, A .
EUROPEAN JOURNAL OF PEDIATRICS, 1998, 157 (05) :368-377
[23]  
Einfeld SL, 2006, AM J MENT RETARD, V111, P193, DOI 10.1352/0895-8017(2006)111[193:MIPS]2.0.CO
[24]  
2
[25]   Methodological issues in interviewing and using self-report questionnaires with people with mental retardation [J].
Finlay, WML ;
Lyons, E .
PSYCHOLOGICAL ASSESSMENT, 2001, 13 (03) :319-335
[26]  
GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO
[27]  
2-6
[28]  
GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006
[29]   Prader-Willi and other syndromes associated with obesity and mental retardation [J].
GunayAygun, M ;
Cassidy, SB ;
Nicholls, RD .
BEHAVIOR GENETICS, 1997, 27 (04) :307-324
[30]   Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome [J].
Haqq, AM ;
Farooqi, IS ;
O'Rahilly, S ;
Stadler, DD ;
Rosenfeld, RG ;
Pratt, KL ;
LaFranchi, SH ;
Purnell, JQ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :174-178